IDEX (IEX) News Today

IDEX Corporation (NYSE: IEX) shares have moved higher and are trading near their 12-month high, supported by a generally favorable revision to earnings expectations. The stock is also above its 50-day and 200-day moving averages, although its elevated valuation—about 34 times earnings—could make it sensitive to any forecast disappointments.

• Positive Sentiment: Analysts raised several forward earnings forecasts. Zacks Research lifted its FY2026 EPS estimate to $8.70 from $8.46, Q3 2026 to $2.20 from $2.17, Q1 2027 to $2.11 from $2.09, FY2027 to $9.21 from $9.20, and FY2028 to $10.45 from $10.27. The upgrades suggest expectations for improving earnings momentum beyond the current year. IDEX analyst estimates
• Positive Sentiment: Longer-term earnings growth remains a key support. The FY2028 forecast implies continued expansion from the approximately $8.70 expected for FY2026, while the company’s latest reported quarter exceeded consensus estimates for both revenue and EPS. IDEX financial information
• Neutral Sentiment: Board changes may increase investor focus on governance and valuation. IDEX announced a board resignation and a governance adjustment. The development does not provide a clear operating-impact signal, but investors may scrutinize leadership, capital allocation, and whether the company’s premium valuation is justified. IDEX board resignation and governance adjustment
• Negative Sentiment: Some estimates were reduced. Zacks cut its Q2 2027 EPS forecast to $2.33 from $2.43 and its Q2 2028 forecast to $2.43 from $2.54. These isolated reductions temper the broader upgrade story and could limit upside if investors view them as signs of uneven demand or execution. IDEX revised earnings estimates